Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> MutationFrank J. Accurso, Bonnie W. Ramsey, Steven M. Rowe et al.|New England Journal of Medicine|2010Cited by 802
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutationJohn P. Clancy, Michael W. Konstan, Steven M. Rowe et al.|Thorax|2011Cited by 496
Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung InfectionsKatherine B. Hisert, Pradeep K. Singh, Brenda Grogan et al.|American Journal of Respiratory and Critical Care Medicine|2017Cited by 393
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasisR. William Vandivier, Peter M. Henson, Valerie A. Fadok et al.|Journal of Clinical Investigation|2002Cited by 373
Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasisR. William Vandivier, Peter M. Henson, Valerie A. Fadok et al.|Journal of Clinical Investigation|2002Cited by 324